Fatma Eser

1.1k total citations
45 papers, 630 citations indexed

About

Fatma Eser is a scholar working on Infectious Diseases, Neurology and Epidemiology. According to data from OpenAlex, Fatma Eser has authored 45 papers receiving a total of 630 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Infectious Diseases, 11 papers in Neurology and 10 papers in Epidemiology. Recurrent topics in Fatma Eser's work include COVID-19 Clinical Research Studies (16 papers), Long-Term Effects of COVID-19 (10 papers) and SARS-CoV-2 and COVID-19 Research (7 papers). Fatma Eser is often cited by papers focused on COVID-19 Clinical Research Studies (16 papers), Long-Term Effects of COVID-19 (10 papers) and SARS-CoV-2 and COVID-19 Research (7 papers). Fatma Eser collaborates with scholars based in Türkiye, United Kingdom and United States. Fatma Eser's co-authors include Rahmet Güner, Ayşe Kaya Kalem, İmran Hasanoğlu, Bircan Kayaaslan, Gülay Korukluoğlu, Esragül Akıncı, Bircan Kayaaslan, Deniz Erdem, Gamze Çapa Kaya and Yasemin Coşgun and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Free Radical Biology and Medicine.

In The Last Decade

Fatma Eser

37 papers receiving 614 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fatma Eser Türkiye 12 373 162 114 84 67 45 630
Ayşe Kaya Kalem Türkiye 12 325 0.9× 157 1.0× 99 0.9× 81 1.0× 59 0.9× 48 588
Sameera Al Johani Saudi Arabia 13 598 1.6× 280 1.7× 99 0.9× 46 0.5× 77 1.1× 25 813
Marianna Traugott Austria 13 561 1.5× 187 1.2× 85 0.7× 33 0.4× 53 0.8× 37 797
Jongtak Jung South Korea 12 258 0.7× 85 0.5× 133 1.2× 13 0.2× 65 1.0× 38 541
Andrea Hahn United States 16 304 0.8× 62 0.4× 225 2.0× 94 1.1× 30 0.4× 56 815
Florian Hitzenbichler Germany 18 412 1.1× 108 0.7× 212 1.9× 14 0.2× 49 0.7× 63 833
Mohammed Abukhattab Qatar 14 267 0.7× 160 1.0× 121 1.1× 15 0.2× 32 0.5× 25 511
Miri Hyun South Korea 13 266 0.7× 133 0.8× 86 0.8× 18 0.2× 40 0.6× 36 455
Yvon Ruch France 9 193 0.5× 66 0.4× 98 0.9× 130 1.5× 21 0.3× 31 439

Countries citing papers authored by Fatma Eser

Since Specialization
Citations

This map shows the geographic impact of Fatma Eser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fatma Eser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fatma Eser more than expected).

Fields of papers citing papers by Fatma Eser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fatma Eser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fatma Eser. The network helps show where Fatma Eser may publish in the future.

Co-authorship network of co-authors of Fatma Eser

This figure shows the co-authorship network connecting the top 25 collaborators of Fatma Eser. A scholar is included among the top collaborators of Fatma Eser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fatma Eser. Fatma Eser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kalem, Ayşe Kaya, Fatma Eser, İmran Hasanoğlu, et al.. (2025). Risk factors associated with Candida auris Candidemia: A single-centre retrospective case–control study. Epidemiology and Infection. 153. e131–e131.
2.
Pekel, Aysel, Ferda Öner Erkekol, Rahmet Güner, et al.. (2024). Analysis of peripheral lymphocyte subsets and T-cell exhaustion in SARS-CoV-2 Infection. Tuberkuloz ve Toraks. 72(2). 152–166.
3.
4.
Güner, Rahmet, Ayşe Kaya Kalem, İşil Özkoçak Turan, et al.. (2024). Antibiotic management programme in a tertiary intensive care unit: effects of a carbapenem-restricted period on clinical and laboratory parameters and costs of infections. Journal of Hospital Infection. 148. 87–94. 1 indexed citations
5.
Hasanoğlu, İmran, Bircan Kayaaslan, Güzelali Özdemir, et al.. (2024). Infections after musculoskeletal injuries in earthquake survivors. Joint Diseases and Related Surgery. 35(3). 684–691.
6.
Eser, Fatma, et al.. (2023). Impact of COVID-19 pandemic on diagnosis and treatment access of patients with viral hepatitis in Turkey. The Journal of Infection in Developing Countries. 17(4). 461–467.
7.
Ceylan, Gülay Güleç, Vehap Topçu, Ayşe Kaya Kalem, et al.. (2023). Impact of Inflammation-Related Genes on COVID-19: Prospective Study at Turkish Cohort. The Tohoku Journal of Experimental Medicine. 261(3). 179–185.
8.
9.
10.
11.
Kayaaslan, Bircan, Fatma Eser, İmran Hasanoğlu, et al.. (2022). Development and validation of COVID‐19 associated candidemia score (CAC‐Score) in ICU patients. Mycoses. 66(2). 128–137. 9 indexed citations
12.
Bal, Ceylan, Ayşe Kaya Kalem, Bircan Kayaaslan, et al.. (2022). COVID-19 patients with altered steroid hormone levels are more likely to have higher disease severity. Endocrine. 78(2). 373–379. 6 indexed citations
13.
Candevir, Aslıhan, Ferit Kuşçu, Süheyla Kömür, et al.. (2021). Low immunity against vaccine preventable diseases in Turkish HIV cohort. TURKISH JOURNAL OF MEDICAL SCIENCES. 51(5). 2311–2317. 3 indexed citations
14.
Kayaaslan, Bircan, İhsan Ateş, Rahmet Güner, et al.. (2021). A notable key for estimating the severity of COVID-19: 25-hydroxyvitamin D status. Turkish Journal of Biochemistry. 46(2). 167–172. 4 indexed citations
15.
Kayaaslan, Bircan, et al.. (2021). A case of Hemophagocytic lymphohistiocytosis induced by COVID-19, and review of all cases reported in the literature. The Journal of Infection in Developing Countries. 15(11). 1607–1614. 11 indexed citations
16.
Okumuş, Nurullah, Neşe Demirtürk, Rıza Aytaç Çeti̇nkaya, et al.. (2021). Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients. BMC Infectious Diseases. 21(1). 411–411. 62 indexed citations
17.
Kalem, Ayşe Kaya, Bircan Kayaaslan, Salim Neşeli̇oğlu, et al.. (2021). A useful and sensitive marker in the prediction of COVID-19 and disease severity: Thiol. Free Radical Biology and Medicine. 166. 11–17. 24 indexed citations
18.
Hasanoğlu, İmran, Gülay Korukluoğlu, Yasemin Coşgun, et al.. (2020). Higher viral loads in asymptomatic COVID-19 patients might be the invisible part of the iceberg. Infection. 49(1). 117–126. 73 indexed citations
19.
Güner, Rahmet, İmran Hasanoğlu, Bircan Kayaaslan, et al.. (2020). COVID-19 experience of the major pandemic response center in the capital: results of the pandemic’s first month in Turkey. TURKISH JOURNAL OF MEDICAL SCIENCES. 50(8). 1801–1809. 29 indexed citations
20.
YILMAZ, Gül Ruhsar, Tümer Güven, Rahmet Güner, et al.. (2013). Tularemia During Pregnancy: Three Cases. Vector-Borne and Zoonotic Diseases. 14(2). 171–173. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ayşe Kaya Kalem Breakdown of academic impact, for papers by Sameera Al Johani Breakdown of academic impact, for papers by Marianna Traugott Breakdown of academic impact, for papers by Jongtak Jung Breakdown of academic impact, for papers by Andrea Hahn Breakdown of academic impact, for papers by Florian Hitzenbichler Breakdown of academic impact, for papers by Mohammed Abukhattab Breakdown of academic impact, for papers by Miri Hyun Breakdown of academic impact, for papers by Yvon Ruch
Rankless by CCL
2026